Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 1;27(1):78-80.
doi: 10.5588/ijtld.22.0454.

Characterising cause of death among people treated for drug-susceptible TB in India

Affiliations

Characterising cause of death among people treated for drug-susceptible TB in India

S R Cox et al. Int J Tuberc Lung Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: none declared.

Figures

Figure
Figure
TB treatment status at time of death among 99 adults (age: ≥18 years) enrolled in two pooled prospective cohorts in Pune and Chennai, India, between December 2013 and November 2018. Previously published algorithm to classify TB-related deaths, including possible, probable, and bacteriologically confirmed. Mutually exclusive treatment status categories used: intensive phase = treatment ongoing and treatment initiated <2 months prior to death (n = 16); continuation phase = treatment ongoing and treatment initiated 2–6 months prior to death (n = 14); treatment failure = positive on smear or culture during the final 2 months of treatment (n = 35); defaulted = treatment prematurely discontinued (n = 12); confirmed TB recurrence = positive on smear or culture after completing treatment (n = 4); probable TB recurrence=clinical evidence of TB after completing treatment (n = 6).

References

    1. World Health Organization. Global tuberculosis report, 2021. Geneva, Switzerland: WHO, 2021.
    1. Central TB Division, Ministry of Health and Family Welfare, Government of India. India TB Report 2022: coming together to end TB altogether. New Delhi, India: GoI, 2022.
    1. Romanowski K, et al. Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2019;19(10):1129–1137. - PubMed
    1. Selvaraju S, et al. Long-term survival of treated tuberculosis patients in comparison to a general population in South India: a matched cohort study. Int J Infect Dis 2021;110:385–393. - PubMed
    1. Mave V, et al. Diabetes mellitus and tuberculosis treatment outcomes in Pune, India. Open Forum Infect Dis 2021;8(4): ofab097. - PMC - PubMed

Publication types

LinkOut - more resources